vs
ALLIENT INC（ALNT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是ALLIENT INC的1.4倍（$197.9M vs $143.4M），REPLIGEN CORP净利率更高（6.7% vs 4.5%，领先2.3%），ALLIENT INC同比增速更快（17.5% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $11.7M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -1.2%）
Allient Inc是一家全球化技术制造企业，主营精密运动、控制及电源解决方案的设计、生产与分销，核心服务航空航天、国防、医疗设备、工业自动化、商用出行等领域，业务覆盖北美、欧洲及亚太地区。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ALNT vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$143.4M
营收增速更快
ALNT
高出3.8%
13.6%
净利率更高
RGEN
高出2.3%
4.5%
自由现金流更多
RGEN
多$5.9M
$11.7M
两年增速更快
RGEN
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $143.4M | $197.9M |
| 净利润 | $6.4M | $13.3M |
| 毛利率 | 32.4% | 52.5% |
| 营业利润率 | 7.9% | 9.0% |
| 净利率 | 4.5% | 6.7% |
| 营收同比 | 17.5% | 13.6% |
| 净利润同比 | 111.8% | 143.9% |
| 每股收益（稀释后） | $0.38 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALNTRGEN
| Q4 25 | $143.4M | $197.9M | ||
| Q3 25 | $138.7M | $188.8M | ||
| Q2 25 | $139.6M | $182.4M | ||
| Q1 25 | $132.8M | $169.2M | ||
| Q4 24 | $122.0M | $174.1M | ||
| Q3 24 | $125.2M | $154.9M | ||
| Q2 24 | $136.0M | $154.1M | ||
| Q1 24 | $146.7M | $151.3M |
净利润ALNTRGEN
| Q4 25 | $6.4M | $13.3M | ||
| Q3 25 | $6.5M | $14.9M | ||
| Q2 25 | $5.6M | $14.9M | ||
| Q1 25 | $3.6M | $5.8M | ||
| Q4 24 | $3.0M | $-30.3M | ||
| Q3 24 | $2.1M | $-654.0K | ||
| Q2 24 | $1.1M | $3.3M | ||
| Q1 24 | $6.9M | $2.1M |
毛利率ALNTRGEN
| Q4 25 | 32.4% | 52.5% | ||
| Q3 25 | 33.3% | 53.2% | ||
| Q2 25 | 33.2% | 50.0% | ||
| Q1 25 | 32.2% | 53.6% | ||
| Q4 24 | 31.5% | 26.1% | ||
| Q3 24 | 31.4% | 50.0% | ||
| Q2 24 | 29.9% | 49.8% | ||
| Q1 24 | 32.3% | 49.5% |
营业利润率ALNTRGEN
| Q4 25 | 7.9% | 9.0% | ||
| Q3 25 | 8.8% | 8.9% | ||
| Q2 25 | 8.4% | 7.6% | ||
| Q1 25 | 6.6% | 3.9% | ||
| Q4 24 | 5.3% | -17.7% | ||
| Q3 24 | 5.3% | -5.1% | ||
| Q2 24 | 3.6% | 1.0% | ||
| Q1 24 | 8.2% | 1.3% |
净利率ALNTRGEN
| Q4 25 | 4.5% | 6.7% | ||
| Q3 25 | 4.7% | 7.9% | ||
| Q2 25 | 4.0% | 8.2% | ||
| Q1 25 | 2.7% | 3.4% | ||
| Q4 24 | 2.5% | -17.4% | ||
| Q3 24 | 1.7% | -0.4% | ||
| Q2 24 | 0.8% | 2.2% | ||
| Q1 24 | 4.7% | 1.4% |
每股收益（稀释后）ALNTRGEN
| Q4 25 | $0.38 | $0.24 | ||
| Q3 25 | $0.39 | $0.26 | ||
| Q2 25 | $0.34 | $0.26 | ||
| Q1 25 | $0.21 | $0.10 | ||
| Q4 24 | $0.17 | $-0.55 | ||
| Q3 24 | $0.13 | $-0.01 | ||
| Q2 24 | $0.07 | $0.06 | ||
| Q1 24 | $0.42 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.7M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $301.5M | $2.1B |
| 总资产 | $577.6M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ALNTRGEN
| Q4 25 | $40.7M | $767.6M | ||
| Q3 25 | $39.5M | $748.7M | ||
| Q2 25 | $49.9M | $708.9M | ||
| Q1 25 | $47.8M | $697.2M | ||
| Q4 24 | $36.1M | $757.4M | ||
| Q3 24 | $37.1M | $784.0M | ||
| Q2 24 | $31.3M | $809.1M | ||
| Q1 24 | $31.5M | $780.6M |
总债务ALNTRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALNTRGEN
| Q4 25 | $301.5M | $2.1B | ||
| Q3 25 | $294.2M | $2.1B | ||
| Q2 25 | $289.1M | $2.1B | ||
| Q1 25 | $272.8M | $2.0B | ||
| Q4 24 | $264.9M | $2.0B | ||
| Q3 24 | $272.9M | $2.0B | ||
| Q2 24 | $265.7M | $2.0B | ||
| Q1 24 | $267.1M | $2.0B |
总资产ALNTRGEN
| Q4 25 | $577.6M | $2.9B | ||
| Q3 25 | $585.1M | $2.9B | ||
| Q2 25 | $588.1M | $2.9B | ||
| Q1 25 | $586.9M | $2.9B | ||
| Q4 24 | $575.8M | $2.8B | ||
| Q3 24 | $596.4M | $2.8B | ||
| Q2 24 | $595.8M | $2.9B | ||
| Q1 24 | $611.6M | $2.8B |
负债/权益比ALNTRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $11.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 8.1% | 8.9% |
| 资本支出强度资本支出/营收 | 1.3% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.12× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $49.7M | $93.9M |
8季度趋势，按日历期对齐
经营现金流ALNTRGEN
| Q4 25 | $13.6M | $25.7M | ||
| Q3 25 | $4.7M | $48.1M | ||
| Q2 25 | $24.5M | $28.6M | ||
| Q1 25 | $13.9M | $15.0M | ||
| Q4 24 | $12.4M | $39.2M | ||
| Q3 24 | $12.1M | $49.3M | ||
| Q2 24 | $8.2M | $42.2M | ||
| Q1 24 | $9.2M | $44.7M |
自由现金流ALNTRGEN
| Q4 25 | $11.7M | $17.6M | ||
| Q3 25 | $2.8M | $43.4M | ||
| Q2 25 | $22.4M | $21.5M | ||
| Q1 25 | $12.9M | $11.4M | ||
| Q4 24 | $9.6M | $33.6M | ||
| Q3 24 | $10.5M | $42.3M | ||
| Q2 24 | $5.8M | $37.4M | ||
| Q1 24 | $6.2M | $36.4M |
自由现金流率ALNTRGEN
| Q4 25 | 8.1% | 8.9% | ||
| Q3 25 | 2.0% | 23.0% | ||
| Q2 25 | 16.0% | 11.8% | ||
| Q1 25 | 9.7% | 6.8% | ||
| Q4 24 | 7.9% | 19.3% | ||
| Q3 24 | 8.4% | 27.3% | ||
| Q2 24 | 4.3% | 24.3% | ||
| Q1 24 | 4.2% | 24.0% |
资本支出强度ALNTRGEN
| Q4 25 | 1.3% | 4.1% | ||
| Q3 25 | 1.4% | 2.5% | ||
| Q2 25 | 1.5% | 3.9% | ||
| Q1 25 | 0.8% | 2.1% | ||
| Q4 24 | 2.3% | 3.2% | ||
| Q3 24 | 1.3% | 4.5% | ||
| Q2 24 | 1.7% | 3.1% | ||
| Q1 24 | 2.0% | 5.5% |
现金转化率ALNTRGEN
| Q4 25 | 2.12× | 1.93× | ||
| Q3 25 | 0.72× | 3.23× | ||
| Q2 25 | 4.36× | 1.92× | ||
| Q1 25 | 3.92× | 2.57× | ||
| Q4 24 | 4.11× | — | ||
| Q3 24 | 5.75× | — | ||
| Q2 24 | 7.13× | 12.70× | ||
| Q1 24 | 1.33× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALNT
| Industrial And Electronics | $69.5M | 48% |
| Vehicle | $25.7M | 18% |
| Other | $20.9M | 15% |
| Aerospace And Defense | $20.6M | 14% |
| Distribution And Other Target Market | $6.7M | 5% |
RGEN
暂无分部数据
